Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Development of Method for Emulsion Stability – V 2.0

Posted on By

Analytical Method Development: SOP for Development of Method for Emulsion Stability – V 2.0

Standard Operating Procedure for Development of Method for Emulsion Stability in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/262/2025
Supersedes SOP/AMD/262/2022
Page No. Page 1 of 13
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To establish a standard method for assessing the stability of pharmaceutical emulsions through a combination of physical observation, droplet size analysis, and accelerated stress tests to ensure

formulation integrity over shelf-life.

2. Scope

This SOP applies to the Analytical Method Development (AMD) team responsible for evaluating the physical and chemical stability of oil-in-water (O/W) and water-in-oil (W/O) emulsions during development, optimization, and stability studies.

3. Responsibilities

  • Analytical Scientist: Executes the emulsion stability testing procedure and documents results.
  • QC Analyst: Supports in sample labeling, conditioning, and monitoring at intervals.
  • QA Executive: Reviews all data, test reports, and ensures regulatory compliance with validated protocols.
See also  Analytical Method Development: SOP for Filter Compatibility Testing in Dissolution - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for the scientific soundness, validation, and regulatory alignment of the emulsion stability evaluation method.

5. Procedure

5.1 Parameters for Stability Evaluation

  1. Physical appearance (phase separation, creaming, color change)
  2. Globule/droplet size measurement
  3. pH determination
  4. Viscosity measurement
  5. Zeta potential (optional for ionic emulsions)

5.2 Sample Preparation

  1. Mix the emulsion sample thoroughly before testing to ensure uniformity.
  2. Dispense required volumes for analysis and storage in respective stress chambers.

5.3 Storage Conditions for Accelerated Testing

  • Long-term: 25°C ± 2°C / 60% RH ± 5%
  • Accelerated: 40°C ± 2°C / 75% RH ± 5%
  • Refrigerated: 5°C ± 3°C
  • Freeze-thaw cycles: -20°C to 25°C, 6 cycles

5.4 Evaluation Time Points

  • 0 (Initial), 1 week, 2 weeks, 1 month, 3 months, and 6 months

5.5 Droplet Size Measurement

  1. Use laser diffraction or optical microscopy for droplet size analysis.
  2. Record D10, D50, and D90 values at each time point.
  3. Document presence of bimodal distribution or coalescence.
See also  Analytical Method Development: Archiving Method Development Reports - V 2.0

5.6 pH and Viscosity Monitoring

  1. Measure pH using a calibrated pH meter (Annexure-2) at each interval.
  2. Measure viscosity using a Brookfield viscometer with appropriate spindle at 25°C.

5.7 Physical Observation

  1. Inspect visually for:
    • Phase separation
    • Creaming or sedimentation
    • Color change
    • Odor change
  2. Document observations in the Stability Observation Log (Annexure-1).

5.8 Acceptance Criteria

  • No phase separation, no significant creaming after 3 months at accelerated condition
  • Droplet size change < ±10% over baseline (D50)
  • pH change within ±0.5 units of initial value
  • Viscosity variation within ±15%

5.9 Method Validation

  1. Repeatability: RSD ≤ 5% for droplet size and viscosity measurements
  2. Robustness: Stability observed under light exposure, agitation, and varying temperature

6. Abbreviations

  • O/W: Oil in Water
  • W/O: Water in Oil
  • RH: Relative Humidity
  • RSD: Relative Standard Deviation

7. Documents

  1. Stability Observation Log – Annexure-1
  2. pH and Viscosity Measurement Log – Annexure-2
  3. Validation Summary Report – Annexure-3

8. References

  • ICH Q1A(R2): Stability Testing of New Drug Substances and Products
  • USP <729>: Globule Size Distribution in Lipid Injectable Emulsions
  • WHO TRS Guidelines on Pharmaceutical Development

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Tanvi Mehra Rakesh Pawar Sunita Reddy
Designation Formulation Analyst QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Stability Observation Log

Date Condition Phase Separation Creaming Color Change Status
21/05/2025 40°C / 75% RH None None No change Pass

Annexure-2: pH and Viscosity Measurement Log

Date pH Viscosity (cP) Status
21/05/2025 5.8 4600 Pass

Annexure-3: Validation Summary Report

Method validated across three emulsion types. Droplet size RSD = 2.4%, pH variation within ±0.3 units, viscosity within ±10%. The method is robust under temperature and light stress. Suitable for ongoing formulation stability programs.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Added freeze-thaw cycle study and zeta potential option Annual Review Sunita Reddy
10/04/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: SOP for Method to Determine Phase Separation in Gels - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: How to Set Up KPIs for SOP Adherence
Next Post: Inconsistent Deviation Documentation Procedures: Undermining GMP Data Integrity

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version